Meitav Investment House’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Meitav Investment House’s Portfolio IBDX Stock Details IBDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.63M	Buy	104,670 +39,761	+61%	+$1M	0.02%	168
2026 Q1	$1.64M	Sell	64,909 -1,501	-2%	-$38.3K	0.02%	142
2025 Q4	$1.69M	Buy	66,410 +7,796	+13%	+$200K	0.02%	151
2025 Q3	$1.5M	Buy	58,614 +22,292	+61%	+$566K	0.02%	145
2025 Q2	$917K	Buy	36,322 +3,677	+11%	+$91.2K	0.01%	150
2025 Q1	$815K	Buy	+32,645	New	+$807K	0.02%	148

Other funds holding IBDX

ACA

Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SIC

Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Klingman & Associates New York $2.35B AUM 23.18% 1-Year Est. Return

Meitav Investment House's IBDX Position: Q2 2026 in Review

Meitav Investment House increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 61% in Q2 2026, buying an estimated $1M and bringing the position to 104,670 shares worth $2.63M. The position accounts for 0.02% of the portfolio, ranked #168.

Meitav Investment House first reported a position in IBDX in Q1 2025 and has held it in 6 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

Meitav Investment House held 104,670 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $2.63M as of Q2 2026.
Meitav Investment House bought 39,761 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $1M.
iShares iBonds Dec 2032 Term Corporate ETF made up 0.02% of Meitav Investment House's portfolio in Q2 2026, its #168 holding.
Meitav Investment House first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q1 2025 and has held it in 6 quarters since.
228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Meitav Investment House's 13F filing for Q2 2026, filed 20 Jul 2026.